Last10K.com

Biotech Acquisition Co (BIOT) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

BIOT Quarterly Reports

    10-Q Quarterly Report August 2022
  • 10-Q Quarterly Report May 2022
  • 10-Q Quarterly Report November 2021
    10-Q Quarterly Report August 2021
    10-Q Quarterly Report May 2021

Biotech Acquisition Co

CIK: 1825413 Ticker: BIOT
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 16, 2022
Document Information Line Items  
Entity Registrant NameBIOTECH ACQUISITION COMPANY 
Trading SymbolBIOT 
Document Type10-Q 
Current Fiscal Year End Date--12-31 
Amendment Flagfalse 
Entity Central Index Key0001825413 
Entity Current Reporting StatusYes 
Entity Filer CategoryNon-accelerated Filer 
Document Period End DateMar. 31, 2022 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ1 
Entity Small Businesstrue 
Entity Emerging Growth Companytrue 
Entity Shell Companytrue 
Entity Ex Transition Periodfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number001-39935 
Entity Incorporation, State or Country CodeE9 
Entity Tax Identification Number00-0000000 
Entity Address, Address Line One545West 25th Street 
Entity Address, Address Line Two20th Floor 
Entity Address, City or TownNewYork 
Entity Address, State or ProvinceNY 
Entity Address, Postal Zip Code10001 
City Area Code(212) 
Local Phone Number227-1905 
Title of 12(b) SecurityClass A ordinary shares included as part of the units 
Security Exchange NameNASDAQ 
Entity Interactive Data CurrentYes 
Class A Ordinary Shares  
Document Information Line Items  
Entity Common Stock, Shares Outstanding 23,000,000
Class B Ordinary Shares  
Document Information Line Items  
Entity Common Stock, Shares Outstanding 5,750,000

View differences made from one quarter to another to evaluate Biotech Acquisition Co's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biotech Acquisition Co.

Continue

Assess how Biotech Acquisition Co's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biotech Acquisition Co's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parentheticals)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Changes In Shareholders??? Deficit (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Accounting Policies, By Policy (Policies)
Commitments
Commitments (Details)
Description Of Organization And Business Operations
Description Of Organization And Business Operations (Details)
Fair Value Measurements
Fair Value Measurements (Details)
Fair Value Measurements (Details) - Schedule Of Binomial Lattice Model For Warrants
Fair Value Measurements (Details) - Schedule Of Changes In The Fair Value Of Level 3 Warrant Liabilities
Fair Value Measurements (Details) - Schedule Of Company???S Assets And Liabilities That Are Measured At Fair Value On A Recurring Basis
Fair Value Measurements (Tables)
Initial Public Offering
Initial Public Offering (Details)
Private Placement
Private Placement (Details)
Related Party Transactions
Related Party Transactions (Details)
Shareholders??? Deficit
Shareholders??? Deficit (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Details) - Schedule Of Basic And Diluted Net Income Per Common Share
Summary Of Significant Accounting Policies (Details) - Schedule Of Condensed Consolidated Balance Sheets Are Reconciled
Summary Of Significant Accounting Policies (Tables)
Warrants
Warrants (Details)

Material Contracts, Statements, Certifications & more

Biotech Acquisition Co provided additional information to their SEC Filing as exhibits

Ticker: BIOT
CIK: 1825413
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-22-027093
Submitted to the SEC: Mon May 16 2022 4:07:00 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Blank Checks

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/biot/0001213900-22-027093.htm